186 related articles for article (PubMed ID: 26852175)
21. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma.
Chang KP; Wang CI; Pickering CR; Huang Y; Tsai CN; Tsang NM; Kao HK; Cheng MH; Myers JN
Head Neck; 2017 Jun; 39(6):1131-1137. PubMed ID: 28230921
[TBL] [Abstract][Full Text] [Related]
22. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
[TBL] [Abstract][Full Text] [Related]
23. TERT promoter mutation in adult granulosa cell tumor of the ovary.
Pilsworth JA; Cochrane DR; Xia Z; Aubert G; Färkkilä AEM; Horlings HM; Yanagida S; Yang W; Lim JLP; Wang YK; Bashashati A; Keul J; Wong A; Norris K; Brucker SY; Taran FA; Krämer B; Staebler A; van Meurs H; Oliva E; Shah SP; Kommoss S; Kommoss F; Gilks CB; Baird DM; Huntsman DG
Mod Pathol; 2018 Jul; 31(7):1107-1115. PubMed ID: 29449679
[TBL] [Abstract][Full Text] [Related]
24. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes.
Vinagre J; Nabais J; Pinheiro J; Batista R; Oliveira RC; Gonçalves AP; Pestana A; Reis M; Mesquita B; Pinto V; Lyra J; Cipriano MA; Ferreira MG; Lopes JM; Sobrinho-Simões M; Soares P
Sci Rep; 2016 Jul; 6():29714. PubMed ID: 27411289
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Stern JL; Hibshman G; Hu K; Ferrara SE; Costello JC; Kim W; Tamayo P; Cech TR; Huang FW
Mol Cancer Res; 2020 Jul; 18(7):1050-1062. PubMed ID: 32276990
[TBL] [Abstract][Full Text] [Related]
26. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
Martínez N; Camacho FI; Algara P; Rodríguez A; Dopazo A; Ruíz-Ballesteros E; Martín P; Martínez-Climent JA; García-Conde J; Menárguez J; Solano F; Mollejo M; Piris MA
Cancer Res; 2003 Dec; 63(23):8226-32. PubMed ID: 14678979
[TBL] [Abstract][Full Text] [Related]
27. Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.
Palma M; Parker A; Hojjat-Farsangi M; Forster J; Kokhaei P; Hansson L; Osterborg A; Mellstedt H
Exp Hematol; 2013 Jul; 41(7):615-26. PubMed ID: 23548418
[TBL] [Abstract][Full Text] [Related]
28. TERT promoter mutation in sebaceous neoplasms.
Muñoz-Jiménez MT; Blanco L; Ruano Y; Carrillo R; Santos-Briz Á; Riveiro-Falkenbach E; Requena L; Kutzner H; Garrido MC; Rodríguez-Peralto JL
Virchows Arch; 2021 Sep; 479(3):551-558. PubMed ID: 33768319
[TBL] [Abstract][Full Text] [Related]
29. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
Arita H; Narita Y; Fukushima S; Tateishi K; Matsushita Y; Yoshida A; Miyakita Y; Ohno M; Collins VP; Kawahara N; Shibui S; Ichimura K
Acta Neuropathol; 2013 Aug; 126(2):267-76. PubMed ID: 23764841
[TBL] [Abstract][Full Text] [Related]
30. TERT promoter mutations in primary and secondary WHO grade III meningioma.
Maier AD; Stenman A; Svahn F; Mirian C; Bartek J; Juhler M; Zedenius J; Broholm H; Mathiesen T
Brain Pathol; 2021 Jan; 31(1):61-69. PubMed ID: 32805769
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma.
Ek S; Ortega E; Borrebaeck CA
Leuk Res; 2005 Feb; 29(2):205-13. PubMed ID: 15607370
[TBL] [Abstract][Full Text] [Related]
32. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
[TBL] [Abstract][Full Text] [Related]
33. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
Labussière M; Boisselier B; Mokhtari K; Di Stefano AL; Rahimian A; Rossetto M; Ciccarino P; Saulnier O; Paterra R; Marie Y; Finocchiaro G; Sanson M
Neurology; 2014 Sep; 83(13):1200-6. PubMed ID: 25150284
[TBL] [Abstract][Full Text] [Related]
34. Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
Del Giudice I; Messina M; Chiaretti S; Santangelo S; Tavolaro S; De Propris MS; Nanni M; Pescarmona E; Mancini F; Pulsoni A; Martelli M; Di Rocco A; Finolezzi E; Paoloni F; Mauro FR; Cuneo A; Guarini A; Foà R
Br J Haematol; 2012 Mar; 156(5):601-11. PubMed ID: 22150124
[TBL] [Abstract][Full Text] [Related]
35. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
[TBL] [Abstract][Full Text] [Related]
36. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
[TBL] [Abstract][Full Text] [Related]
37. Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.
Fujio S; Juratli TA; Takajo T; Arita K; Nagano Y; Yoshimoto K; Nayyar N; Curry WT; Martinez-Lage M; Cahill DP; Barker FG; Brastianos PK
Neurol Med Chir (Tokyo); 2021 Jun; 61(6):385-391. PubMed ID: 33967180
[TBL] [Abstract][Full Text] [Related]
38. Familial lymphoid neoplasms in patients with mantle cell lymphoma.
Tort F; Camacho E; Bosch F; Harris NL; Montserrat E; Campo E
Haematologica; 2004 Mar; 89(3):314-9. PubMed ID: 15020270
[TBL] [Abstract][Full Text] [Related]
39. Telomere length in mantle cell lymphoma.
Jebaraj BM; Kienle D; Lechel A; Mertens D; Heuberger M; Ott G; Rosenwald A; Barth TF; Möller P; Zenz T; Döhner H; Stilgenbauer S
Blood; 2013 Feb; 121(7):1184-7. PubMed ID: 23243283
[TBL] [Abstract][Full Text] [Related]
40. Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.
Schneider S; Crescenzi B; Schneider M; Ascani S; Hartmann S; Hansmann ML; Falini B; Mecucci C; Tiacci E; Küppers R
Int J Cancer; 2014 Feb; 134(4):832-43. PubMed ID: 23929122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]